Lot 1
No lot description published.
Statuscomplete
AwardedFind a Tender · award
INHERITED CANCER GENETICS
BuyerCardiff and Vale University Health Board
StatusAwarded
DeadlineNot published
ValueValue not published
Published9 Jul 2026
What is being bought
Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.
Lot details
Comparable-procurement analytics
No usable CPV category has been published, so a comparable market set cannot yet be built.
Procurement strategy & market signals
Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleSingle supplier – technical reasons The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways. The identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption. Furthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk. Single supplier – unique work of art or performance (proprietary justification) The service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements. The supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable. Any change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.
Rationale classificationssingleSuppliersIntellectualPropertyExclusiveRights, singleSuppliersTechnicalReasons
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published
Planning & early market engagement
BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0
No planning milestones published.
Related procurements
No linked framework, prior procurement or reprocurement published.
Awards
1
Statusactive
SupplierInformed Genetics
Contracts
INHERITED CANCER GENETICS
Statusactive
Value£450,000
Documents & submission route
- Not published
Source data inventory
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-06bcee |
|---|---|
| Latest release ID | 064441-2026 |
| Latest release timestamp | Thu Jul 09 2026 07:23:07 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | complete |
| Procurement method | direct |
| Procurement method details | Direct award |
| Main procurement category | Not published |
| Above threshold | Not published |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 0 |
| Tender documents in source | 1 |
| Awards in latest release | 1 |
| Contracts in latest release | 1 |
| Parties in latest release | 3 |
Notice history
| Date | Event | Reference |
|---|---|---|
| 9 Jul 2026 | award, contract | 064441-2026 |
| 25 Jun 2026 | award, contract | 059805-2026 |
| 25 Jun 2026 | award, contract | 059783-2026 |
All source data
Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "064441-2026",
"tag": [
"award",
"contract"
],
"date": "2026-07-09T08:23:07+01:00",
"ocid": "ocds-h6vhtk-06bcee",
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "85148000",
"scheme": "CPV",
"description": "Medical analysis services"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "services"
}
],
"tender": {
"id": "CAV-DIR (26-27) 49",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "INHERITED CANCER GENETICS",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "Single supplier – technical reasons The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways. The identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption. Furthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk. Single supplier – unique work of art or performance (proprietary justification) The service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements. The supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable. Any change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersIntellectualPropertyExclusiveRights"
},
{
"id": "singleSuppliersTechnicalReasons"
}
]
},
"parties": [
{
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board",
"roles": [
"buyer"
],
"address": {
"region": "UKL22",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"countryName": "United Kingdom",
"streetAddress": "Woodland House"
},
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Welsh devolved regulations apply"
}
]
},
"identifier": {
"id": "PPPR-7969-BTJG",
"scheme": "GB-PPON"
},
"contactPoint": {
"name": "Nicola Williams",
"email": "Nicola.williams33@wales.nhs.com",
"telephone": "+442921500649"
}
},
{
"id": "GB-PPON-PXWV-6492-CGMN",
"name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
"roles": [
"procuringEntity"
],
"address": {
"region": "UKL15",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"countryName": "United Kingdom",
"streetAddress": "4-5 Charnwood Court Heol Billingsley"
},
"identifier": {
"id": "PXWV-6492-CGMN",
"scheme": "GB-PPON"
},
"roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.",
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics",
"roles": [
"supplier"
],
"address": {
"region": "UKG31",
"country": "GB",
"locality": "Birmingham",
"postalCode": "B32 1AF",
"countryName": "United Kingdom",
"streetAddress": "Unit 5, quinton business park,11 Ridgeway"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PZXY-1897-VDDJ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Izzie.Coakley@nonacus.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "INHERITED CANCER GENETICS",
"value": {
"amount": 450000,
"currency": "GBP",
"amountGross": 540000
},
"period": {
"endDate": "2027-12-31T23:59:59+00:00",
"startDate": "2027-01-01T00:00:00+00:00"
},
"status": "active",
"awardID": "1",
"documents": [
{
"id": "A-18951",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-18951",
"format": "application/pdf",
"documentType": "contractSigned"
},
{
"id": "064441-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/064441-2026",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2026-07-09T08:23:07+01:00"
}
],
"dateSigned": "2026-07-08T00:00:00+01:00",
"aboveThreshold": true
}
],
"initiationType": "tender"
}Complete JSON history (3 releases)
9 Jul 2026 · 064441-2026 · award, contract
{
"id": "064441-2026",
"tag": [
"award",
"contract"
],
"date": "2026-07-09T08:23:07+01:00",
"ocid": "ocds-h6vhtk-06bcee",
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "85148000",
"scheme": "CPV",
"description": "Medical analysis services"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "services"
}
],
"tender": {
"id": "CAV-DIR (26-27) 49",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "INHERITED CANCER GENETICS",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "Single supplier – technical reasons The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways. The identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption. Furthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk. Single supplier – unique work of art or performance (proprietary justification) The service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements. The supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable. Any change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersIntellectualPropertyExclusiveRights"
},
{
"id": "singleSuppliersTechnicalReasons"
}
]
},
"parties": [
{
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board",
"roles": [
"buyer"
],
"address": {
"region": "UKL22",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"countryName": "United Kingdom",
"streetAddress": "Woodland House"
},
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Welsh devolved regulations apply"
}
]
},
"identifier": {
"id": "PPPR-7969-BTJG",
"scheme": "GB-PPON"
},
"contactPoint": {
"name": "Nicola Williams",
"email": "Nicola.williams33@wales.nhs.com",
"telephone": "+442921500649"
}
},
{
"id": "GB-PPON-PXWV-6492-CGMN",
"name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
"roles": [
"procuringEntity"
],
"address": {
"region": "UKL15",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"countryName": "United Kingdom",
"streetAddress": "4-5 Charnwood Court Heol Billingsley"
},
"identifier": {
"id": "PXWV-6492-CGMN",
"scheme": "GB-PPON"
},
"roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.",
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics",
"roles": [
"supplier"
],
"address": {
"region": "UKG31",
"country": "GB",
"locality": "Birmingham",
"postalCode": "B32 1AF",
"countryName": "United Kingdom",
"streetAddress": "Unit 5, quinton business park,11 Ridgeway"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PZXY-1897-VDDJ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Izzie.Coakley@nonacus.com"
}
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "INHERITED CANCER GENETICS",
"value": {
"amount": 450000,
"currency": "GBP",
"amountGross": 540000
},
"period": {
"endDate": "2027-12-31T23:59:59+00:00",
"startDate": "2027-01-01T00:00:00+00:00"
},
"status": "active",
"awardID": "1",
"documents": [
{
"id": "A-18951",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-18951",
"format": "application/pdf",
"documentType": "contractSigned"
},
{
"id": "064441-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/064441-2026",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2026-07-09T08:23:07+01:00"
}
],
"dateSigned": "2026-07-08T00:00:00+01:00",
"aboveThreshold": true
}
],
"initiationType": "tender"
}25 Jun 2026 · 059805-2026 · award, contract
{
"id": "059805-2026",
"tag": [
"award",
"contract"
],
"date": "2026-06-25T12:15:25+01:00",
"ocid": "ocds-h6vhtk-06bcee",
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"awards": [
{
"id": "1",
"date": "2026-06-24T00:00:00+01:00",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "85148000",
"scheme": "CPV",
"description": "Medical analysis services"
}
]
}
],
"title": "INHERITED CANCER GENETICS",
"value": {
"amount": 450000,
"currency": "GBP",
"amountGross": 540000
},
"status": "pending",
"documents": [
{
"id": "059805-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/059805-2026",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2026-06-25T12:15:25+01:00"
}
],
"suppliers": [
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics "
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2026-07-10T23:59:59+01:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-12-31T23:59:59+00:00",
"startDate": "2027-01-01T00:00:00+00:00"
},
"standstillPeriod": {
"endDate": "2026-07-06T23:59:59+01:00"
},
"mainProcurementCategory": "services"
}
],
"tender": {
"id": "CAV-DIR (26-27) 49",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "INHERITED CANCER GENETICS",
"status": "complete",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award"
},
"parties": [
{
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board",
"roles": [
"buyer"
],
"address": {
"region": "UKL22",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"countryName": "United Kingdom",
"streetAddress": "Woodland House"
},
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Welsh devolved regulations apply"
}
]
},
"identifier": {
"id": "PPPR-7969-BTJG",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Nicola.williams33@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PXWV-6492-CGMN",
"name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
"roles": [
"procuringEntity"
],
"address": {
"region": "UKL15",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"countryName": "United Kingdom",
"streetAddress": "4-5 Charnwood Court Heol Billingsley"
},
"identifier": {
"id": "PXWV-6492-CGMN",
"scheme": "GB-PPON"
},
"roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.",
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics ",
"roles": [
"supplier"
],
"address": {
"region": "UKG31",
"country": "GB",
"locality": "Birmingham",
"postalCode": "B32 1AF",
"countryName": "United Kingdom",
"streetAddress": "Unit 5, quinton business park,11 Ridgeway"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "PZXY-1897-VDDJ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Izzie.Coakley@nonacus.com"
}
}
],
"language": "en",
"initiationType": "tender"
}25 Jun 2026 · 059783-2026 · award, contract
{
"id": "059783-2026",
"tag": [
"award",
"contract"
],
"date": "2026-06-25T11:46:50+01:00",
"ocid": "ocds-h6vhtk-06bcee",
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKL22",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "85148000",
"scheme": "CPV",
"description": "Medical analysis services"
}
]
}
],
"title": "Inherited Cancer genetics",
"value": {
"amount": 450000,
"currency": "GBP",
"amountGross": 540000
},
"status": "pending",
"documents": [
{
"id": "059783-2026",
"url": "https://www.find-tender.service.gov.uk/Notice/059783-2026",
"format": "text/html",
"noticeType": "UK5",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2026-06-25T11:46:50+01:00"
}
],
"suppliers": [
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics"
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2026-07-08T23:59:59+01:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-12-31T23:59:59+00:00",
"startDate": "2027-01-01T00:00:00+00:00"
},
"mainProcurementCategory": "services"
}
],
"tender": {
"id": "CAV-DIR (26-27) 49",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "INHERITED CANCER GENETICS ",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.\nThis service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.\nThe selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.\nIntroducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.\nAwarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways.\nThe identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption.\nFurthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk.\nThe service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements.\nThe supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable.\nAny change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersTechnicalReasons"
},
{
"id": "singleSuppliersUniqueWorkArtPerformance"
}
]
},
"parties": [
{
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board ",
"roles": [
"buyer"
],
"address": {
"region": "UKL22",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"countryName": "United Kingdom",
"streetAddress": "Woodland House "
},
"details": {
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/",
"classifications": [
{
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - sub-central government"
},
{
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Welsh devolved regulations apply"
}
]
},
"identifier": {
"id": "PPPR-7969-BTJG",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Nicola.williams33@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PXWV-6492-CGMN",
"name": "NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)",
"roles": [
"procuringEntity"
],
"address": {
"region": "UKL15",
"country": "GB",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"countryName": "United Kingdom",
"streetAddress": "4-5 Charnwood Court Heol Billingsley"
},
"identifier": {
"id": "PXWV-6492-CGMN",
"scheme": "GB-PPON"
},
"roleDetails": "The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.",
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
}
},
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics",
"roles": [
"supplier"
],
"address": {
"region": "UKG31",
"country": "GB",
"locality": "Birmingham",
"postalCode": "B32 1AF",
"countryName": "United Kingdom",
"streetAddress": "Unit 5, quinton business park,11 Ridgeway,"
},
"details": {
"vcse": false,
"scale": "large"
},
"identifier": {
"id": "PZXY-1897-VDDJ",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "Izzie.Coakley@nonacus.com"
}
}
],
"language": "en",
"initiationType": "tender"
}